Frequency News and Research

RSS

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

25 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

Vasculitis damage swift, accumulating

Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.

22 Nov 2013

Scientists hope to find new treatments for traumatic brain injury

In the most wide-reaching project of its kind, scientists at the University of Texas Medical Branch are expanding their research on traumatic brain injury, examining its progressive, chronic effects on the body in hopes of treating its immediate and long-term consequences. The project is funded by a three-year, $9 million grant from The Moody Foundation of Galveston.

22 Nov 2013

Electronic health records may be used to measure patient-centeredness of primary care practices

Although electronic health records (EHR) are primarily used to store patient clinical data, the non-clinical data they collect may be used to measure patient-centeredness of primary care practices, finds a new study in Health Services Research. In addition, two of the process of care measures collected via EHRs, volume of between clinician e-messages and frequency of in-person patient visits, were associated with better patient health outcomes.

22 Nov 2013

QoL, BMI predict exacerbations in Japanese COPD patients

Analysis of a cohort of Japanese chronic obstructive pulmonary disease patients with a low exacerbation frequency shows that low body mass index and poor health-related quality of life independently predict flare ups of the disease.

21 Nov 2013

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Because of its participation in a pivotal trial, Henry Ford Hospital will be the first in Michigan to offer electric stimulation of the brain using a newly FDA-approved device for hard-to-treat epilepsy cases.

21 Nov 2013

Study finds high rate of anisometropia in older adults

Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 Nov 2013

UK's first gene therapy trial for patients with chronic heart failure begins at GJNH

The UK’s first gene therapy trial for advanced heart failure, CUPID 2, has officially begun at the Golden Jubilee National Hospital; with the first candidate recently being administered with a dose of the MYDICAR treatment.

21 Nov 2013

Linde Healthcare introduces intelligent digital oxygen cylinders with integrated pressure regulators

The new generation of oxygen cylinders, with an integrated pressure regulator that calculates and shows remaining time to the exact minute. LIV IQ is also equipped with various visible and audible alerts which enhance patient safety in mobile oxygen therapy. All together, these features free up time for healthcare professionals to concentrate on the patient and enable a cost-effective use of cylinder content.

20 Nov 2013

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection.

18 Nov 2013

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (AREDS2) clinical centers, executed by the EMMES Corporation and sponsored by Notal Vision Ltd. Tel Aviv, Israel, have been accepted for publication in Ophthalmology.

16 Nov 2013

Errors in medication common on admission to mental health services, shows study

A recent study, published in the International Journal of Clinical Pharmacy, involving Aston University (UK), South Essex Partnership University NHS Foundation Trust (SEPT) and the University of East Anglia (UK) found medication errors were common on admission to mental health services.

16 Nov 2013

Studies prove that students use prescription drugs to enhance cognitive performance

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

16 Nov 2013

Competitive gymnasts have higher exposure to harmful flame-retardants, shows study

Competitive gymnasts have a higher exposure to potentially harmful flame-retardants than the general population, likely because such contaminants are present in foam used in gym equipment, a study led by Boston University School of Public Health researchers has found.

15 Nov 2013

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

The risk of cardiovascular complications in people with type 2 diabetes is directly related to the frequency and duration of physical exercise, according to results of a large follow-up study reported today on World Diabetes Day. Notably, those with low levels of physical activity had a 70% greater risk of cardiovascular death than those with higher levels.

15 Nov 2013

Researchers use new approach to parse roles of key mutated protein that causes familial AD

Researchers at the University of California, San Diego School of Medicine have used genetic engineering of human induced pluripotent stem cells to specifically and precisely parse the roles of a key mutated protein in causing familial Alzheimer's disease, discovering that simple loss-of-function does not contribute to the inherited form of the neurodegenerative disorder.

15 Nov 2013

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

14 Nov 2013

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.

14 Nov 2013

Frequency News and Research

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Vasculitis damage swift, accumulating

Scientists hope to find new treatments for traumatic brain injury

Electronic health records may be used to measure patient-centeredness of primary care practices

QoL, BMI predict exacerbations in Japanese COPD patients

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Study finds high rate of anisometropia in older adults

UK's first gene therapy trial for patients with chronic heart failure begins at GJNH

Linde Healthcare introduces intelligent digital oxygen cylinders with integrated pressure regulators

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Experts develop new working formulation for reporting of cardiac antibody-mediated rejection

Study shows patients at high-risk of CNV benefit from ForeseeHome device for earlier detection

Errors in medication common on admission to mental health services, shows study

Studies prove that students use prescription drugs to enhance cognitive performance

Competitive gymnasts have higher exposure to harmful flame-retardants, shows study

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

Researchers use new approach to parse roles of key mutated protein that causes familial AD

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News